AlphaMadera's AlphaVal page computes McCormick & Company, Incorporated's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag MKC as undervalued, fairly valued, or overvalued.

What is McCormick & Company, Incorporated's fair value?

Fair value for MKC is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value MKC?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from MKC's most recent reported fundamentals.

MKC - McCormick & Company, Incorporated

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $61.40 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Fair Value Moderate

Trading 20.5% below fair value

Current Price $51.67

Bear Case $53.50 3.5% upside ($53.50 - $51.67) / $51.67 = 3.5% $3.91 × 14x P/E

Fair Value $64.96 25.7% upside ($64.96 - $51.67) / $51.67 = 25.7% $3.91 × 17x P/E

Bull Case $76.43 47.9% upside ($76.43 - $51.67) / $51.67 = 47.9% $3.91 × 20x P/E

Adjust Assumptions

P/E Multiple

17.0x

Adjusted EPS

3.91$

Key Value Driver

Normalized P/E multiple (17x base case)

Implied Market Multiple 13.2x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $61.40 from 30 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $64.96 per share.

Warnings

⚠ The company's reported profits differ from official accounting profits by 33%. Check what costs are being left out of the adjusted number.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples